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Abstract Abstracted
• Pluripotent stem cells with Huntington’s disease break down more
protein than normal pluripotent stem cells
• However, pre-neurons with Huntington’s disease break down less
protein
• Lastly, neurons with Huntington’s disease break down even less
protein
• However, a transcription factor which increases how much
proteasomes (complexes which break down proteins) act increases
how much total protein is broken down
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• Proteasomes break down misfolded
proteins
• Protein degradation is important to
maintain proteasis
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• Huntington’s disease is a proteinopathy
(caused by abnormal protein: mHtt)
• Proteasis is disrupted
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• Proteasomes degrade the cytotoxic
mHtt aggregates

Introduction
Ectoderm
• Some
epithelial
tissue
• Nerve tissue
• Salivary
glands
Endoderm
• Glands that
form secretions
in digestive tract
• Epithelium of
the bladder

PSCs

Mesoderm
• Muscles
• Bone and
cartilage
• Blood cells

• Pluripotent stem cells can
differentiate into any type of
cell in the body
• To maintain pluripotency,
maintenance of proteasis is
important
• Environmental factors can
stimulate PSCs to differentiate
specifically

Methods
PSCs

NPCs

Neurons

• Pluripotent stem cells
• Can differentiate into any cell
type

• Neural progenitor cells
• Believed to hold the potential
to differentiate into any cell
type in the CNS

• Effectors of the brain
• Communicate through action
potentials

• Liu et al. transfected the PSCs with HD-inducing
(high CAG repeat length) plasmids
• The proteasome activity in each cell type (HD +
control)
• FOXO levels were also measured
• FOXO1
• FOXO3a
• FOXO4
• FOXO6

Results
• HD iPSCs maintained normal
morphology and pluripotency
• HD iPSCs exhibited greater FOXO1
and FOXO4 expression
• Knockdown of FOXO4 only
lowered proteasomal function

Results
Before FOXO4 overexpression

After FOXO4 overexpression

• NPC (control + HD) exhibited lower
proteasomal function and FOXO1 and
FOXO4 expression
• HD cells now experienced lower
proteasomal function than their
control counterparts
• FOXO4 overexpression rescued
proteasomal function in HD NPCs

Results
• Proteasomal function in HD iPSCderived neurons was lower than
control neurons
• SOX2 degradation rate was
significantly lower in the HD neurons
• FOXO4 expression significantly
differed between control and HD
mice

Conclusions
HD cells compared to controls

• HD iPSCs maintained pluripotency
• FOXO4, but not FOXO1, mediates
proteasomal function in HD
• FOXO4 overexpression rescued
proteasomal function in HD NPCs
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Discussion Questions
1. What would you like to see in stem cell research?
2. Gene therapy (HD iPSC generation, FOXO1/FOXO4
knockdown, FOXO4 overexpession) was used. What
potential do you see in gene therapy?
3. Do you think we should explore more diseasemanipulating treatments, or should we quench the
issue before solving it?

